Literature DB >> 3904233

Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.

A J Wilson, M Baum, D M Brinkley, J A Dossett, K McPherson, J S Patterson, R D Rubens, F G Smiddy, B A Stoll, D Richards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3904233     DOI： 10.1007/bf01655191

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  15 in total

1.  Long-term survival of women with breast cancer.

Authors:  D Brinkley; J L Haybittle
Journal:  Lancet       Date:  1984-05-19       Impact factor: 79.321

2.  Review of mortality results in randomised trials in early breast cancer.

Authors: 
Journal:  Lancet       Date:  1984-11-24       Impact factor: 79.321

3.  Effect of adjuvant therapy in primary breast cancer in relation to the estrogen receptor level.

Authors:  A Wallgren; U Glas; S Gustafsson; L Skoog; N O Theve; B Nordenskjöld
Journal:  Recent Results Cancer Res       Date:  1984

4.  Adjuvant tamoxifen therapy for early breast cancer: an experimental study with reference to oestrogen and progesterone receptors.

Authors:  A J Wilson; F Tehrani; M Baum
Journal:  Br J Surg       Date:  1982-03       Impact factor: 6.939

5.  Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values.

Authors:  C Rose; S M Thorpe; K W Andersen; B V Pedersen; H T Mouridsen; M Blichert-Toft; B B Rasmussen
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

Review 6.  Chemotherapy of breast cancer: current views and results.

Authors:  G Bonadonna; P Valagussa
Journal:  Int J Radiat Oncol Biol Phys       Date:  1983-03       Impact factor: 7.038

7.  Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.

Authors:  B Fisher; C Redmond; E R Fisher; M Bauer; N Wolmark; D L Wickerham; M Deutsch; E Montague; R Margolese; R Foster
Journal:  N Engl J Med       Date:  1985-03-14       Impact factor: 91.245

8.  Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute.

Authors:  G Ribeiro; M K Palmer
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-12

9.  The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings.

Authors:  B Fisher; C Redmond; E R Fisher
Journal:  Cancer       Date:  1980-08-15       Impact factor: 6.860

10.  Prospects for the future in the management of carcinoma of the breast: the biological fall out from clinical trials.

Authors:  M Baum
Journal:  Br J Cancer       Date:  1984-02       Impact factor: 7.640
View more
  6 in total

Review 1.  Gynecologic effects of tamoxifen: case reports and review of the literature.

Authors:  R M Caputo; L J Copeland
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1996

2.  Progesterone binding cyst protein (PBCP) in primary breast cancer: a new prognostic factor?

Authors:  J A Søreide; O A Lea; S Kvinnsland
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

Review 3.  The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.

Authors:  R Vihko; A Alanko; V Isomaa; A Kauppila
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

4.  Partial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsiveness.

Authors:  Bhupendra Singh; Nimee K Bhat; Hari K Bhat
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

5.  Cyclophosphamide and tamoxifen as adjuvant therapies in the management of breast cancer. CRC Adjuvant Breast Trial Working Party.

Authors: 
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

6.  Prednisolone improves the response to primary endocrine treatment for advanced breast cancer.

Authors:  R D Rubens; C L Tinson; R E Coleman; R K Knight; D Tong; P J Winter; W R North
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.